Gugliotta G.; Castagnetti F.; Palandri F.; Breccia M.; Intermesoli T.; Capucci A.; Martino B.; Pregno P.; Rupoli S.; Ferrero D.; Gherlinzoni F.; Montefusco E.; Bocchia M.; Tiribelli M.; Pierri I.; Grifoni F.; Marzocchi G.; Amabile M.; Testoni N.; Martinelli G.; Alimena G.; Pane F.; Saglio G.; Baccarani M.; Rosti G., Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party., «BLOOD», 2011, 117(21), pp. 5591 - 5599 [articolo]
Soverini S; Gnani A; De Benedittis C; Castagnetti F; Gugliotta G; Iacobucci I; Palandri F; Rosti G; Testoni N; Luatti S; Marzocchi G; Baccarani M; Martinelli G, Low-level Bcr-Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib, «LEUKEMIA RESEARCH», 2011, 35, pp. 1527 - 1529 [articolo]
Marzocchi G.; Castagnetti F.; Luatti S.; Baldazzi C.; Stacchini M.; Gugliotta G.; Amabile M.; Specchia G.; Sessarego M.; Giussani U.; Valori L.; Discepoli G.; Montaldi A.; Santoro A.; Bonaldi L.; Giudici G.; Cianciulli A.M.; Giacobbi F.; Palandri F.; Pane F.; Saglio G.; Martinelli G.; Baccarani M.; Rosti G.; Testoni N., Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis., «BLOOD», 2011, 117(25), pp. 6793 - 6800 [articolo]
Baldazzi C; Iacobucci I; Luatti S; Ottaviani E; Marzocchi G; Paolini S;
Stacchini M; Papayannidis C; Gamberini C; Martinelli G; Baccarani M; Testoni N., B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene., «LEUKEMIA RESEARCH», 2010, 34, pp. 282 - 285 [articolo]
Zaccaria A; Testoni N; Valenti AM; Luatti S; Tonelli M; Marzocchi G; Cipriani R; Baldazzi C; Giannini B; Stacchini M; Gamberini C; Castagnetti F; Rosti G; Azzena A; Cavazzini F; Cianciulli AM; Dalsass A; Donti E; Giugliano E; Gozzetti A; Grimoldi MG; Ronconi S; Santoro A; Spedicato F; Zanatta L; Baccarani M, Chromosome abnormalities additional to the Philadelphia
chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications., «CANCER GENETICS AND CYTOGENETICS», 2010, 199, pp. 76 - 80 [articolo]
Castagnetti F; Testoni N;Luatti S; Marzocchi G; Mancini M; Kerim S;
Giugliano E; Albano F; Cuneo A;Abruzzese E; Martino B; Palandri F;
Amabile M; Iacobucci I; Alimena G; Pane F; Martinelli G; Saglio G; Baccarani M; Rosti G, Deletionsof the derivative chromosome 9 do not influence the response
and the outcomeof chronic myeloid leukemia in early chronic phase
treated with imatinibmesylate: GIMEMA CML Working Party analysis, «JOURNAL OF CLINICAL ONCOLOGY», 2010, 28(16), pp. 2748 - 2754 [articolo]
Matteucci C; Barba G; Varasano E; Vitale A; Mancini M; Testoni N; Cuneo A; Rege-Cambrin G; Elia L; La Starza R; Pierini V; Brandimarte L; Vignetti M; Foà R; Mecucci C., Rescue of genomic information in adult acute lymphoblastic leukaemia (ALL) with normal/failed cytogenetics: a GIMEMA centralized biological study., «BRITISH JOURNAL OF HAEMATOLOGY», 2010, 149, pp. 70 - 78 [articolo]
Palandri F; Castagnetti F; Iacobucci I; Martinelli G; Amabile M; Gugliotta G; Poerio A; Testoni N; Breccia M; Bocchia M; Crugnola M; Rege-Cambrin G; Martino B; Pierri I; Radaelli F; Specchia G; Pane F; Saglio G; Rosti G; Baccarani M, The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase., «HAEMATOLOGICA», 2010, 95, pp. 1415 - 1419 [articolo]
Haferlach C; Mecucci C; Schnittger S; Kohlmann A; Mancini M; Cuneo A; Testoni N; Rege-Cambrin G; Santucci A; Vignetti M; Fazi P; Martelli MP; Haferlach T; Falini B., AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features., «BLOOD», 2009, 114, pp. 3024 - 3032 [articolo]
Testoni N; Marzocchi G; Luatti S; Amabile M; Baldazzi C; Stacchini M; Nanni M; Rege-Cambrin G; Giugliano E; Giussani U; Abruzzese E; Kerim S; Grimoldi MG; Gozzetti A; Crescenzi B; Carcassi C; Bernasconi P; Cuneo A; Albano F; Fugazza G; Zaccaria A; Martinelli G; Pane F; Rosti G; Baccarani M., Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response, a study of the GIMEMA CML WP., «BLOOD», 2009, 114(24), pp. 4939 - 4943 [articolo]
Baccarani M; Rosti G; Castagnetti F; Haznedaroglu I; Porkka K; Abruzzese E; Alimena G; Ehrencrona H; Hjorth-Hansen H; Kairisto V; Levato L; Martinelli G; Nagler A; Nielsen JL; Ozbek U; Palandri F; Palmieri F; Pane F; Rege-Cambrin G; Russo D; Specchia G; Testoni N; Weiss-Bjerrum O; Saglio G; Simonsson B., Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of patients with high risk, Philadelphia-positive, chronic myeloid leukaemia: a European LeukemiaNet study, «BLOOD», 2009, 113(19), pp. 504 - 4497 [articolo]
Piccaluga PP; Sabattini E; Bacci F; Agostinelli C; Righi S; Salmi F; Testoni N; Paolini S; Castagnetti F; Martinelli G; Falini B; Pileri SA., Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia., «LEUKEMIA», 2009, 23, pp. 1370 - 1371 [articolo]
Baldazzi C; Luatti S; Marzocchi G; Stacchini M; Gamberini C; Castagnetti F; Palandri F; Rosti G; Baccarani M; Testoni N., Emergence of clonal chromosomal abnormalities in Philadelphia negative hematopoiesis in chronic myeloid leukemia patients treated with nilotinib after failure of imatinib therapy, «LEUKEMIA RESEARCH», 2009, 33, pp. e218 - e220 [articolo]
Palandri F; Testoni N; Luatti S; Marzocchi G; Baldazzi C; Stacchini M; Castagnetti F; Breccia M; Specchia G; Pane F; Saglio G; Martinelli G; Baccarani M; Rosti G., Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results., «LEUKEMIA & LYMPHOMA», 2009, 50(1), pp. 114 - 118 [articolo]
Palandri F; Catani L; Testoni N; Ottaviani E; Polverelli N; Fiacchini M; De Vivo A; Salmi F; Lucchesi A; Baccarani M; Vianelli N., Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy., «AMERICAN JOURNAL OF HEMATOLOGY», 2009, 84(4), pp. 215 - 220 [articolo]
